NCT07630402
- Conditions
- Breast Cancer With Low to Intermediate HER2 Expression
- Locations
-
- Wilmot Cancer Center Rochester, New York, United States
Clinical trial condition
Breast Cancer With Low to Intermediate HER2 Expression
Explore clinical trials studying Breast Cancer With Low to Intermediate HER2 Expression. Study availability and eligibility vary by location and protocol.
4 public trials
2 recruiting studies
Breast Cancer With Low to Intermediate HER2 Expression trial results
NCT07331506
- Conditions
- Breast Cancer (Early Breast Cancer), Breast Cancer - Ductal Carcinoma in Situ (DCIS), Breast Cancer - Female, +11 more
- Locations
-
- DIM Centros de Salud Buenos Aires, Argentina
Not Yet Recruiting
Application of Multimodal MRI-based Radiomics in Histological Grading and Prognostic Assessment of Breast Cancer
NCT07389200
- Conditions
- Breast Cancer, Breast Cancer With Low to Intermediate HER2 Expression, Breast Diseases, +5 more
- Locations
-
Not specified
NCT01479244
- Conditions
- Breast Cancer With Low to Intermediate HER2 Expression, Breast Diseases, Breast Neoplasms, +4 more
- Locations
-
- Alabama Oncology Bessemer, Alabama, United States
- Physicians Pain Specialists of Alabama, P.C. Mobile, Alabama, United States
- Pain Centers Nationwide Peoria, Arizona, United States
- Valley Pain Consultants Scottsdale, Arizona, United States